Skip to main content

Table 1 Characteristics of patients with colorectal cancer and liver metastases undergoing SIR therapy

From: Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy

 

Median

Range

Age

62.6 years

35.3 - 77.9 years

Time to SIRT after primary diagnosis

25 months

6-140

 

Number

Percentage (%)

Patients

49

100

Gender

  

   Female

16

32.7

   Male

33

67.3

Localisation of primary tumor

  

   Colon

11

22.5

   Sigma

22

44.0

   Rectum

16

32.5

Chemotherapies before SIRT

  

FOLFOX

42

85.7

FOLFIRI

47

95.9

Therapy response

  

   REM

9

18.4

   SD

5

10.2

   PD

35

71.4

   Progression defining

  

   liver metastases

19

54.3

   extrahepatic manifestation

6

17.1

   deceased

10

28.6

One year survival*

  

   Yes

22

45.8

   No

26

54.2

 

Median

95% Conf. Interval

Overall survival

8.8 months

5.1-18.1

  1. * one patient lost to follow-up